secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK:        0000879407
Form:       8-K
Filed at:   2023-02-14T23:59:59+00:00
Accession:  0001628280-23-003560
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Marianne De Backer resigns from Arrowhead board effective April 2, 2023
--------------------------------------------------------------------------------

- Marianne De Backer notified Arrowhead of her resignation as director, effective April 2, 2023.
- De Backer served as independent director, on Audit, Compensation, and as Chair of Nomination Committee.
- Resignation due to her appointment as CEO and director of Vir Biotechnology; no disagreement with Arrowhead.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879407/000162828023003560/0001628280-23-003560-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879407/000162828023003560/arwr-20230211.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-003560

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer